Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D FROHLICH

Showing results (61-70 of 361) with videos related to

Pageof 37
Sort By:
Cardiology|January 1, 1985
Antihypertensive therapy: newer concepts and agentsE D Frohlich
Journal of Cardiovascular Pharmacology|June 8, 2001
Renin-angiotensin system inhibition improves coronary flow reserve in hypertensionE D Frohlich
American Journal of Hypertension|June 20, 2001
Fibrosis and ischemia: the real risks in hypertensive heart diseaseE D Frohlich
Ochsner Journal|May 24, 2011
An updated concept for left ventricular hypertrophy risk in hypertensionEdward D Frohlich
Cardiovascular Clinics|January 1, 1990
Left ventricular hypertrophy: an independent factor of riskE D Frohlich
The American Journal of Medicine|September 26, 1983
Physiologic considerations in left ventricular hypertrophyE D Frohlich
Journal of Molecular and Cellular Cardiology|December 1, 1989
Overview of hemodynamic and non-hemodynamic factors associated with left ventricular hypertrophyE D Frohlich
Current Problems in Cardiology|July 16, 2017
Evolution of American Academic Medicine: A View of Its Contributions to World Medicine and Reflections Influenced by Personal Role ModelsEdward D Frohlich
Journal of Clinical Hypertension|March 1, 1987
Pathophysiological considerations in left ventricular hypertrophyE D Frohlich
The American Journal of Cardiology|January 23, 1987
Potential mechanisms explaining the risk of left ventricular hypertrophyE D Frohlich
Pageof 37

Showing results (61-70 of 361) with videos related to

Sort By:
Pageof 37
Cardiology|January 1, 1985
Antihypertensive therapy: newer concepts and agentsE D Frohlich
Journal of Cardiovascular Pharmacology|June 8, 2001
Renin-angiotensin system inhibition improves coronary flow reserve in hypertensionE D Frohlich
American Journal of Hypertension|June 20, 2001
Fibrosis and ischemia: the real risks in hypertensive heart diseaseE D Frohlich
Ochsner Journal|May 24, 2011
An updated concept for left ventricular hypertrophy risk in hypertensionEdward D Frohlich
Cardiovascular Clinics|January 1, 1990
Left ventricular hypertrophy: an independent factor of riskE D Frohlich
The American Journal of Medicine|September 26, 1983
Physiologic considerations in left ventricular hypertrophyE D Frohlich
Journal of Molecular and Cellular Cardiology|December 1, 1989
Overview of hemodynamic and non-hemodynamic factors associated with left ventricular hypertrophyE D Frohlich
Current Problems in Cardiology|July 16, 2017
Evolution of American Academic Medicine: A View of Its Contributions to World Medicine and Reflections Influenced by Personal Role ModelsEdward D Frohlich
Journal of Clinical Hypertension|March 1, 1987
Pathophysiological considerations in left ventricular hypertrophyE D Frohlich
The American Journal of Cardiology|January 23, 1987
Potential mechanisms explaining the risk of left ventricular hypertrophyE D Frohlich
Pageof 37